Capitol Hill Hearing Examines Meningitis Outbreak

A subpoena ordered Barry Cadden, president and co-owner of the New England Compounding Center, to appear at the Nov. 14 hearing and testify.

Members of the U.S. House Energy & Commerce Committee's Oversight and Investigations Subcommittee waded into the fungal meningitis outbreak linked to contaminated injectable steroid medications from the New England Compounding Center (NECC) during a lengthy Nov. 14 hearing about the outbreak and whether it could have been prevented.

Many members pelted questions at Dr. Margaret Hamburg, FDA commissioner, asking whether her agency had the authority to shut down NECC's operations before this outbreak occurred. Hamburg steadfastly testified that a "patchwork" of laws and conflicting federal court decisions had limited FDA's authority. Several members asked her to turn over emails and records of past communications concerning NECC between FDA and the Massachusetts Department of Public Health, which has been jointly investigating Framingham, Mass.-based NECC with the FDA since Oct. 1.

Joyce Lovelace, the widow of Eddie Lovelace, 78, a circuit judge who died Sept. 18 after receiving one of the steroid injections at an outpatient surgical clinic in Nashville, and Dr. Lauren Smith, interim commissioner of the Massachusetts Department of Public Health, also testified during the hearing.

As of Nov. 8, the death toll had risen to 32 and a total of 438 cases in 19 states, CDC reported. Twenty-three of the cases are in Florida, the home state of subcommittee Chairman Cliff Stearns.

The subcommittee posted a copy of the subpoena issued to Barry Cadden, president and co-owner of NECC, ordering him to appear at the hearing and testify. He invoked his Fifth Amendment right against self-incrimination in electing not to answer questions under oath about the causes of the contamination. The company has surrendered its license, shut down its operations, and recalled all of its products.

"NECC knowingly disregarded sterility tests, preparing medicine in unsanitary conditions and unlawfully engaged in manufacturing, endangering thousands of lives as a result," Smith stated in her prepared testimony. "NECC bears the primary responsibility for the harm they have caused with these actions." She discussed emergency regulations enacted in Massachusetts on Nov. 1 as a result of the inquiry and a special commission created to explore how best to strengthen state oversight of sterile compounding pharmacies.

Download Center

HTML - No Current Item Deck
  • Free Safety Management Software Demo

    IndustrySafe Safety Management Software helps organizations to improve safety by providing a comprehensive toolset of software modules to help businesses identify trouble spots; reduce claims, lost days, OSHA fines; and more.

  • Comply with OSHA’s Electronic Recordkeeping Requirements

    Collect relevant incident data and generate accurate OSHA 300, 300A, and 301 regulatory reports, including 300A CSV files for easy electronic submission to OSHA.

  • Complete Online Safety Training Courses

    Deliver state-of-the art, online safety training courses to your organization with IndustrySafe Training Management Software. Generate reports to track training compliance and automatically notify learners of upcoming or overdue classes.

  • Easy to Use Safety Inspection App

    Conduct inspections on the go with IndustrySafe’s mobile app. Complete safety audits at job sites and remote locations—with or without web access.

  • Track Key Safety Performance Indicators

    IndustrySafe’s Dashboard Module allows organizations to easily track safety KPIs and metrics. Gain increased visibility into your business’ operations and safety data.

  • Industry Safe
comments powered by Disqus